Screening for the early detection of disease, the need for evidence

Clinica Chimica Acta

Volumn 315, Issue 1-2, 2002, Pages 5-15

  McQueen, Matthew J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Disease; Evidence; Laboratory medicine; Rules; Screening

Indexed keywords

ACCURACY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST; DOWN SYNDROME; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; HUMAN; HYPERHOMOCYSTEINEMIA; INFORMED CONSENT; LABORATORY; LABORATORY PERSONNEL; LABORATORY TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SCREENING; STANDARD; STREPTOCOCCUS INFECTION; VALIDATION PROCESS;

CANADA; CLINICAL LABORATORY TECHNIQUES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DOWN SYNDROME; ENDOMETRIAL NEOPLASMS; FEMALE; HEALTH PROMOTION; HUMANS; HYPERHOMOCYSTEINEMIA; INFANT, NEWBORN; MASS SCREENING; MULTIPHASIC SCREENING; NEONATAL SCREENING; QUALITY OF HEALTH CARE; STREPTOCOCCAL INFECTIONS; UNITED STATES;

EID: 0036132781     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00709-4     Document Type: Review

References (48)

1. Clinical diagnosis and the clinical laboratory
2. An evaluation of the periodic health examination
3. Some pitfalls in the evaluation of screening programs
4. The usefulness of laboratory tests in health - Screening programs
5. Mortality from cancer of the cervix uteri in British Columbia and other parts of Canada
6. Screening for early detection of disease: To what purpose?
7. Direct and indirect randomized trials of screening: The A's and D's of evidence-based clinical practice guidelines
8. Psychological costs of screening mammography
9. Screening for down's syndrome
10. Effects of labelling on income, work and social function among hypertensive employees
11. Increased absenteeism from work after detection and labelling of hypertensive patients
12. Screening could seriously damage your health. Decisions to screen must take account of social and psychological costs
13. Preventive Health Care, 2000 update: Screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events
14. Maternal serum screening for Down's syndrome in early pregnancy
15. Effect of screening algorithm, parameter values and median smoothing on patient-specific risk estimates for Down's syndrome screening
16. Prenatal screening for Down's syndrome
17. Combining ultrasound and biochemistry in first-trimester screening for Down syndrome
18. Integrated screening for Down syndrome based on tests performed during the first and second trimesters
19. Neonatal group B Streptococcal disease - Screening and prevention
20. Prevention of perinatal group B streptococcal disease: A public health perspective
21. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
22. Rapid detection of group B streptococci in pregnant women at delivery
23. Laboratory practices for prenatal group B streptococcal screening and reporting - Connecticut, Georgia and Minnesota, 1997-1998
24. Evidence-based medicine: Its application in laboratory medicine
25. The folly of population screening for type 2 diabetes
26. Preventive medicine in people at high risk for chronic disease: The value of identifying and treating diabetes
27. Assessing the clinical effectiveness of preventive maneuvers: Analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations
28. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
29. Early photocoagulation in patients with either type 1 or type 2 diabetes
30. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: A randomized prospective 6-year study
31. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: A seven-year follow-up study
32. Management of diabetes mellitus from a public health perspective
33. Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: A prospective study using office endometrial biopsy
34. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: A prospective long-term study using transvaginal ultrasound
35. The normal, and the perils of the sylleptic argument
36. The value of routine preoperative medical testing before cataract surgery
37. Evaluation of benefits of screening tests done immediately on admission to hospital
38. Biochemical profiles for hospital patients
39. Opportunistic discovery of occult disease by use of test panels in new, symptomatic primary care outpatients: Yield and cost of care finding
40. Common diagnostic test panels for clinical evaluation of new primary care outpatients in Japan: A cost-effective evaluation
41. Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism
42. Should we screen for gestational diabetes? "The concept of gestational diabetes was popularized before considerations of evidence based medicine came on the scene"
43. The case for screening for gestational diabetes
44. Screening for gestational diabetes mellitus
45. Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: Prospective population based study
46. Number needed to screen: Development of a statistic for disease screening
47. A number to treat (NNT) analysis of the prevention of myocardial infarction and death by dyslipidemic therapy